Biomarkers in Saliva and Stool
Understanding Innate and Adaptive Immunological Response in Stool and Saliva Samples in Healthy Donors
1 other identifier
observational
86
1 country
1
Brief Summary
To collect saliva and stool samples using the salimetrics swab and self-stool collection kit, process and store samples in a standardized manner. Following this, perform immunological assays such as enzyme-linked immunosorbent assay, multiplex bead assay and Immunocap to correlate the salivary and fecal levels of biomarkers in healthy donors. As this method is non-invasive, we believe that more people will be willing to donate samples.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2015
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 11, 2015
CompletedFirst Submitted
Initial submission to the registry
September 26, 2017
CompletedFirst Posted
Study publicly available on registry
September 29, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2017
CompletedMarch 12, 2018
December 1, 2017
2.8 years
September 26, 2017
March 9, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Establish methods to detect immune markers in non-invasive samples: Saliva and stool in healthy volunteers
ELISA RSV specific Immunoglobulin in saliva
1 year after completion of recruitment
Establish methods to detect immune markers in non-invasive samples: Saliva and stool in healthy volunteers
ELISA Rotavirus specific Immunoglobulin in stool
1 year after completion of recruitment
Secondary Outcomes (2)
Difference in RSV-specific Immunoglobulins between age groups.
1 year after completion of primary outcome
Difference in RSV-specific Immunoglobulins between age groups.
1 year after completion of primary outcome
Other Outcomes (2)
Establish methods to detect immune markers in non-invasive samples: Saliva and stool in healthy volunteers
1 year after completion of primary outcome
Establish methods to detect immune markers in non-invasive samples: Saliva and stool in healthy volunteers
1 year after completion of primary outcome
Interventions
No intervention, this is an observational study
Eligibility Criteria
Healthy Volunteers in Singapore between 0 and 60 years of age
You may qualify if:
- Healthy volunteers of age 0-60 years old
You may not qualify if:
- Volunteers with any known infectious diseases, such as HIV and Hepatitis B
- Volunteers with any acute or chronic illness, such as chronic inflammatory bowel disease (e.g. Crohn's disease or ulcerative colitis)
- Volunteers with oral diseases/ulcers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Danone Nutricia Research
Singapore, 138671, Singapore
Biospecimen
Saliva, Stool samples
Study Officials
- PRINCIPAL INVESTIGATOR
Elena Sandalova, PhD
Nutricia Research
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 26, 2017
First Posted
September 29, 2017
Study Start
March 11, 2015
Primary Completion
December 31, 2017
Study Completion
December 31, 2017
Last Updated
March 12, 2018
Record last verified: 2017-12
Data Sharing
- IPD Sharing
- Will not share
IDP is not going to be shared.